Literature DB >> 16354824

Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children.

Kirsten E Lyke1, Alassane Dicko, Abdoulaye Dabo, Lansana Sangare, Abdoulaye Kone, Drissa Coulibaly, Ando Guindo, Karim Traore, Modibo Daou, Issa Diarra, Marcelo B Sztein, Christopher V Plowe, Ogobara K Doumbo.   

Abstract

Plasmodium falciparum and Schistosoma haematobium are co-endemic parasitic diseases with worldwide distribution. Evidence suggests interactions occur between helminthic and malaria infections, although it is unclear whether this effect is beneficial or harmful to the host. Malian children 4-14 years of age with asymptomatic S. haematobium infection (SP) (n = 338) were prospectively matched by age, sex, and residence to children without schistosomiasis (SN) (n = 338) who were cleared of occult intestinal parasites, and followed-up for one malaria transmission season (25 weeks). The time to the first clinical malaria infection, incidence of malaria episodes, and parasitemia were recorded. Age associated protection from malaria in children with schistosomiasis was observed. SP children (4-8 years of age) compared with SN children demonstrated delayed time to first clinical malaria infection (74 versus 59 days; P = 0.04), fewer numbers of malaria episodes (1.55 versus 1.81 infections; P = 0.03) and lower geometric mean parasite densities (6,359 versus 9,874 asexual forms/mm(3); P = 0.07) at first infection. No association between schistosomiasis and P. falciparum malaria was observed in children 9-14 years of age. We conclude that underlying schistosomiasis is associated with protection against clinical falciparum malaria in an age-dependent manner.

Entities:  

Mesh:

Year:  2005        PMID: 16354824      PMCID: PMC2738948     

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  35 in total

1.  Factors affecting the intensity of reinfection with Schistosoma haematobium following treatment with praziquantel.

Authors:  S K Chandiwana; M E Woolhouse; M Bradley
Journal:  Parasitology       Date:  1991-02       Impact factor: 3.234

2.  Impaired balance of interleukin-4 and interferon-gamma production in infections with Schistosoma mansoni and intestinal nematodes.

Authors:  K Zwingenberger; A Hohmann; M C de Brito; M Ritter
Journal:  Scand J Immunol       Date:  1991-08       Impact factor: 3.487

3.  Age-acquired resistance and predisposition to reinfection with Schistosoma haematobium after treatment with praziquantel in Mali.

Authors:  J F Etard; M Audibert; A Dabo
Journal:  Am J Trop Med Hyg       Date:  1995-06       Impact factor: 2.345

4.  Gene-targeted mice lacking B cells are unable to eliminate a blood stage malaria infection.

Authors:  T von der Weid; N Honarvar; J Langhorne
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

5.  Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity.

Authors:  C L King; A Medhat; I Malhotra; M Nafeh; A Helmy; J Khaudary; S Ibrahim; M El-Sherbiny; S Zaky; R J Stupi; K Brustoski; M Shehata; M T Shata
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

Review 6.  The potential for recruiting immune responses toward type 1 or type 2 T cell help.

Authors:  B Golding; M Zaitseva; H Golding
Journal:  Am J Trop Med Hyg       Date:  1994       Impact factor: 2.345

7.  Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice.

Authors:  M M Stevenson; M F Tam
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

8.  Interferon-gamma production by peripheral blood mononuclear cells from residents of an area endemic for Schistosoma mansoni.

Authors:  I R Viana; A Sher; O S Carvalho; C L Massara; S M Eloi-Santos; E J Pearce; D G Colley; G Gazzinelli; R Correa-Oliveira
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Jul-Aug       Impact factor: 2.184

9.  Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.

Authors:  E A Sabin; M I Araujo; E M Carvalho; E J Pearce
Journal:  J Infect Dis       Date:  1996-01       Impact factor: 5.226

10.  Schistosomiasis in Dogon country, Mali: identification and prevalence of the species responsible for infection in the local community.

Authors:  D De Clercq; D Rollinson; A Diarra; M Sacko; G Coulibaly; A Landouré; M Traoré; V R Southgate; A Kaukas; J Vercruysse
Journal:  Trans R Soc Trop Med Hyg       Date:  1994 Nov-Dec       Impact factor: 2.184

View more
  71 in total

1.  Assessment of quality of life as a tool for measuring morbidity due to Schistosoma mansoni infection and the impact of treatment.

Authors:  Kimberly Y Won; Bernard Abudho; Anna J Blackstock; Susan P Montgomery; Erin D Kennedy; Bobbie Person; Pauline N M Mwinzi; Elizabeth A Ochola; Karen T Foo; Allen W Hightower; Diana M S Karanja; W Evan Secor
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

2.  Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria/malaria-coinfected population.

Authors:  Simon Metenou; Benoit Dembélé; Siaka Konate; Housseini Dolo; Siaka Y Coulibaly; Yaya I Coulibaly; Abdallah A Diallo; Lamine Soumaoro; Michel E Coulibaly; Dramane Sanogo; Salif S Doumbia; Marissa Wagner; Sekou F Traoré; Amy Klion; Siddhartha Mahanty; Thomas B Nutman
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

3.  Associations Between Helminth Infections, Plasmodium falciparum Parasite Carriage and Antibody Responses to Sexual and Asexual Stage Malarial Antigens.

Authors:  Ulysse Ateba-Ngoa; Sophie Jones; Jeannot Fréjus Zinsou; Josiane Honkpehedji; Ayola Akim Adegnika; Jean-Claude Dejon Agobe; Marguerite Massinga-Loembe; Benjamin Mordmüller; Teun Bousema; Maria Yazdanbakhsh
Journal:  Am J Trop Med Hyg       Date:  2016-06-06       Impact factor: 2.345

4.  Coinfection with Plasmodium falciparum and Schistosoma haematobium: additional evidence of the protective effect of Schistosomiasis on malaria in Senegalese children.

Authors:  Magali Lemaitre; Laurence Watier; Valérie Briand; André Garcia; Jean Yves Le Hesran; Michel Cot
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

Review 5.  Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.

Authors:  Anne E P Frosch; Chandy C John
Journal:  Expert Rev Anti Infect Ther       Date:  2012-11       Impact factor: 5.091

6.  Schistosoma mansoni infection impairs antimalaria treatment and immune responses of rhesus macaques infected with mosquito-borne Plasmodium coatneyi.

Authors:  Amma A Semenya; Joann S Sullivan; John W Barnwell; W Evan Secor
Journal:  Infect Immun       Date:  2012-08-20       Impact factor: 3.441

7.  Antibody isotype analysis of malaria-nematode co-infection: problems and solutions associated with cross-reactivity.

Authors:  Karen J Fairlie-Clarke; Tracey J Lamb; Jean Langhorne; Andrea L Graham; Judith E Allen
Journal:  BMC Immunol       Date:  2010-02-17       Impact factor: 3.615

8.  Malaria and helminth co-infections in outpatients of Alaba Kulito Health Center, southern Ethiopia: a cross sectional study.

Authors:  Abraham Degarege; Abebe Animut; Mengistu Legesse; Berhanu Erko
Journal:  BMC Res Notes       Date:  2010-05-25

9.  Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children.

Authors:  Mahamadou S Sissoko; Abdoulaye Dabo; Hamidou Traoré; Mouctar Diallo; Boubacar Traoré; Drissa Konaté; Boubacar Niaré; Moussa Diakité; Bourama Kamaté; Abdrahamane Traoré; Aboudramane Bathily; Amadou Tapily; Ousmane B Touré; Sarah Cauwenbergh; Herwig F Jansen; Ogobara K Doumbo
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

10.  Schistosoma mansoni infection reduces the incidence of murine cerebral malaria.

Authors:  Judith H Waknine-Grinberg; Daniel Gold; Ariel Ohayon; Eliezer Flescher; Alina Heyfets; Michael J Doenhoff; Gabriele Schramm; Helmut Haas; Jacob Golenser
Journal:  Malar J       Date:  2010-01-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.